deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 2-arm NCT04847739

Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)

Sponsor: Alimentiv Inc.

Conditions Crohn's Disease Perianal Fistula
Interventions AVB-114 Seton Placement
Updated 18 times since 2021 Last updated: Jul 31, 2024 Started: Sep 13, 2021 Primary completion: May 31, 2025 Completion: Aug 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Crohn's Disease and Perianal Fistula and is currently ongoing. Alimentiv Inc. leads this study, which shows 18 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Jan 2022 · 4 months · monthly snapshot~Jan 2022 – ~Mar 2022 · 59 days · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~May 2022 · 30 days · monthly snapshot~May 2022 – ~Jun 2022 · 31 days · monthly snapshot~Jun 2022 – ~Sep 2022 · 3 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Mar 2023 · 4 months · monthly snapshot~Mar 2023 – ~Jun 2023 · 3 months · monthly snapshot~Jun 2023 – ~Jul 2023 · 30 days · monthly snapshot~Jul 2023 – ~Sep 2023 · 2 months · monthly snapshot~Sep 2023 – ~Oct 2023 · 30 days · monthly snapshot~Oct 2023 – ~Jan 2024 · 3 months · monthly snapshot~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

18 versions recorded

  1. Sep 2024 — Present [monthly]

    Active Not Recruiting PHASE2

  2. Aug 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  3. Jul 2024 — Aug 2024 [monthly]

    Recruiting PHASE2

  4. Jan 2024 — Jul 2024 [monthly]

    Recruiting PHASE2

  5. Oct 2023 — Jan 2024 [monthly]

    Recruiting PHASE2

▶ Show 13 earlier versions

  1. Sep 2023 — Oct 2023 [monthly]

    Recruiting PHASE2

  2. Jul 2023 — Sep 2023 [monthly]

    Recruiting PHASE2

  3. Jun 2023 — Jul 2023 [monthly]

    Recruiting PHASE2

  4. Mar 2023 — Jun 2023 [monthly]

    Recruiting PHASE2

  5. Nov 2022 — Mar 2023 [monthly]

    Recruiting PHASE2

  6. Sep 2022 — Nov 2022 [monthly]

    Recruiting PHASE2

  7. Jun 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

  8. May 2022 — Jun 2022 [monthly]

    Recruiting PHASE2

  9. Apr 2022 — May 2022 [monthly]

    Recruiting PHASE2

  10. Mar 2022 — Apr 2022 [monthly]

    Recruiting PHASE2

  11. Jan 2022 — Mar 2022 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  12. Sep 2021 — Jan 2022 [monthly]

    Not Yet Recruiting PHASE2

  13. May 2021 — Sep 2021 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alimentiv Inc.
  • Avobis Bio, LLC
Data source: Avobis Bio, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aurora, United States , Boston, United States , Chicago, United States , Cincinnati, United States , Indianapolis, United States , Jacksonville, United States , Los Angeles, United States , Miami, United States , Nashville, United States , New York, United States and 4 more locations